Dr. Luo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cedar St
New Haven, CT 06510Phone+1 203-432-4771
Education & Training
- University of Oklahoma Health Sciences CenterResidency, Pathology-Anatomic and Clinical, 2013 - 2017
- Beijing Medical UniversityClass of 2001
Certifications & Licensure
- CA State Medical License 2015 - 2025
- CT State Medical License 2022 - 2025
- OK State Medical License 2015 - 2025
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 144 citationsOutcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study.Hamzah Abu-Sbeih, Faisal Ali, Dana Alsaadi, Joseph Jennings, Wenyi Luo
Journal for Immunotherapy of Cancer. 2018-12-05 - 135 citationsImportance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitisHamzah Abu-Sbeih, Faisal Ali, Wenyi Luo, Wei Qiao, Gottumukkala S. Raju
Journal for Immunotherapy of Cancer. 2018-09-25 - 91 citationsZinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic CancerMingyang Liu, Yuqing Zhang, Jingxuan Yang, Hanxiang Zhan, Zhijun Zhou
Gastroenterology. 2021-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: